A gathering of international researchers, physicians, and mental health practitioners, the NAD+ Brain Restoration Summit is designed to present the latest research on the proven and potential applications of NAD (nicotinamide adenine dinucleotide) in treating a wide range of illnesses and conditions—from addiction, anxiety, depression, and trauma, to a host of degenerative diseases, including Parkinson’s, Alzheimer’s, and others associated with aging.
Featured presenters include Dr. Richard Mestayer, who, with his partner Paula Norris Mestayer, are the world’s leading practitioners of intravenous BR+NAD for the treatment of addiction and a host of neurodegenerative diseases. Other confirmed participants include Dr. Jade Berg, Australasian Research Institute and the University of Sydney; Dr. Wei Chen, University of Minnesota; Dr. Patty DiBlasio, MPH, integrative and regenerative medicine specialist; Dr. Krishna Doniparthi, director and physician at Functional Medicine of Georgia; Dr. Susan Broom Gibson, associate professor of psychology, School of Natural and Behavioral Sciences, William Carey University; Dr. Ross Grant, clinical associate professor in pharmacology and neuropharmacology at the University of Sydney Medical School and CEO of the Australasian Research Institute; Dr. Sharon Hausman-Cohen, co-founder, chief science officer, and medical director of IntellxxDNA™; Dr. David Lefer, director of the Cardiovascular Center of Excellence and professor of pharmacology at LSU Health Sciences Center in New Orleans; Dr. Henry Liang, board-certified anesthesiologist and ketamine specialist; Dr. James Paul Watson, clinical faculty, David Geffen School of Medicine, UCLA, and Dr. Xiao-Hong Zhu, research professor at the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota.
The Summit will include poster and case study presentations, with monetary awards for the top three. To submit, email Dr. Richard F. Mestayer at email@example.com.
To register, visit http://www.brplusnadsummit.com/.